AbbVie Inc. against Thermo Fisher Scientific — live side-by-side technical comparison.
Prices as of 2026-10-16T20:00:03+00:00 UTC · updates daily
ABBV leads 4 of the 5 windows we measure — over 1 month ABBV is +8.7% and TMO +6.4%; over year to date ABBV is +24.9% and TMO +19.1%. The ABBV/TMO price ratio stands at 0.4137, above its 50-day average of 0.4126, and below the 200-day average of 0.4306. A ratio above its own average means ABBV is gaining on TMO; on this reading the recent edge belongs to ABBV.
| ABBV | TMO | |
|---|---|---|
| Price | $285.42 | $690.00 |
| 1 day | +0.7%lead | -0.9% |
| 5 days | +3.2% | +4.9%lead |
| 1 month | +8.7%lead | +6.4% |
| 6 months | +36.6%lead | +33.7% |
| Year to date | +24.9%lead | +19.1% |
| 52-week position | 94% of range | 95% of range |
| 52-week range | $190.75–$291.40 | $435.27–$704.00 |
| vs 50-day average | above $262.45 | above $636.69 |
| vs 200-day average | above $233.95 | above $547.32 |
| RSI (14) | 71 | 54 |
| Next earnings | 2026-10-30 | 2026-10-21 |
ABBV trades at $285.42, above its 50-day average of $262.45, and above the 200-day at $233.95. It sits at 94% of its 52-week range ($190.75–$291.40); 14-day RSI is 71, in overbought territory; an average session moves it about 2.4%. For levels, the first level overhead is $300.00 (5.1% away) and the first support below is $275.00 (3.6% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.
TMO trades at $690.00, above its 50-day average of $636.69, and above the 200-day at $547.32. It sits at 95% of its 52-week range ($435.27–$704.00); 14-day RSI is 54, in neutral territory; an average session moves it about 2.9%. For levels, the first level overhead is $696.49 (0.9% away) and the first support below is $650.00 (5.8% down). On the checklist the page runs for every asset, 5 of 6 checks read bullish — the lean is bullish.
TMO is the more volatile of the two — an average session moves it 2.9% against 2.4% for ABBV, so an identical position size carries roughly 1.2× the daily risk.
The comparison turns on those levels: ABBV clearing $300.00 or losing $275.00; TMO clearing $696.49 or losing $650.00. Until one of them gives way, the relative reading above stands.